TAVANIC Side Effects

6726748-1 | Angioedema, Coma
on May 06, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, coma. Tavanic dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ). Patient was hospitalized.

6726747-X | Diarrhoea, Facial Paresis, Guillain-barre Syndrome, Myalgia, Nerve Root Lesion, Sciatica, Swelling
Patient was taking Tavanic (View Usage). Patient had the following side effects: diarrhoea, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), myalgia, nerve root lesion, sciatica (What is sciatica?), swelling on May 06, 2010 from GERMANY Additional patient health information: Female patient , 49 years of age, was diagnosed with sinusitis (What is sinusitis?), arrhythmia (What is arrhythmia?) and. Tavanic dosage: . During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6725607-8 | Clostridium Difficile Colitis, Rotavirus Test Positive, Urosepsis
Adverse event was reported on May 07, 2010 by a Female patient taking Tavanic (View Usage) (Dosage: Film Coated Tablets) was diagnosed with urinary tract infection (What is urinary tract infection?), prophylaxis against gastrointestinal ulcer, diarrhoea, type 2 diabetes mellitus and. Location: JAPAN , 72 years of age, After Tavanic was administered, patient had the following side effects: clostridium difficile colitis, rotavirus test positive, urosepsis. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), SULTAMICILLIN (View Sultamicillin Review and Sultamicillin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), PIPERACILLIN AND TAZOBACTAM (1 Df: 4 G Piperacillin = 0.5 G Tazobactam Powder) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ACTRAPID INSULIN (3x After Value-34 Iu (18/6/10)) (View Actrapid Insulin Review and Actrapid Insulin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6725581-4 | Diarrhoea, Nausea
on May 06, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with bronchitis (What is bronchitis?), chronic obstructive pulmonary disease and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, nausea (What is nausea?). Tavanic dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BEROTEC (View Berotec Review and Berotec Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.


6725580-2 | Back Pain, Dyspnoea, Eye Swelling, Hyperhidrosis, Pain In Extremity, Pharyngeal Oedema
on May 06, 2010 Female patient from JAPAN , 26 years of age, was diagnosed with pyelonephritis and was treated with Tavanic (View Usage). Patient had the following side effects: back pain (What is back pain?), dyspnoea, eye swelling, hyperhidrosis, pain in extremity, pharyngeal oedema. Tavanic dosage: .

6723494-5 | Sepsis, Thrombocytopenia
Patient was taking Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: sepsis (What is sepsis?), thrombocytopenia on May 06, 2010 from JAPAN Additional patient health information: Male patient , 47 years of age, was diagnosed with pneumonia pneumococcal, prophylaxis and. Tavanic dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6723191-6 | Diarrhoea, Dysgeusia, Hyperhidrosis, Muscle Spasms, Parosmia, Tremor
Adverse event was reported on May 06, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, dysgeusia, hyperhidrosis, muscle spasms, parosmia, tremor. During the same period patient was treated with ASS RATIOPHARM (View Ass-ratiopharm Review and Ass-ratiopharm Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DELIX (View Delix Review and Delix Label ).

6720935-4 | Altered State Of Consciousness, Dehydration, Depressed Level Of Consciousness, Dialysis, Malaise, Metabolic Acidosis, Pruritus, Rash
on May 05, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with postoperative wound infection and was treated with Tavanic (View Usage). Patient had the following side effects: altered state of consciousness, dehydration, depressed level of consciousness, dialysis (What is dialysis?), malaise, metabolic acidosis, pruritus, rash (What is rash?). Tavanic dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), IODOFORM (View Iodoform Review and Iodoform Label ), BETADINE (Irrigation) (View Betadine Review and Betadine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMAREL (View Amarel Review and Amarel Label ), TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

6718941-9 | Anaphylactic Shock, Angioedema, Hypotension, Respiratory Disorder, Tremor, Urticaria, Vasoconstriction
on May 07, 2010 Male patient from JAPAN , 59 years of age, was diagnosed with lung disorder and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: anaphylactic shock, angioedema, hypotension, respiratory disorder, tremor, urticaria, vasoconstriction. Tavanic dosage: .

6718937-7 | Arthralgia, Back Pain, Faecal Volume Decreased, Heart Rate Increased, Inflammation, Muscular Weakness, Myalgia, Pain In Extremity, Polymyalgia Rheumatica
Patient was taking Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), faecal volume decreased, heart rate increased, inflammation, muscular weakness, myalgia, pain in extremity, polymyalgia rheumatica (What is polymyalgia rheumatica?) on May 04, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with prostatitis, prostatic specific antigen increased and. Tavanic dosage: .

6718936-5 | Purpura, Renal Failure Acute, Septic Shock, Tubulointerstitial Nephritis
Adverse event was reported on May 04, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with osteitis and. Location: JAPAN , 79 years of age, Patient had the following side effects: purpura, renal failure acute, septic shock, tubulointerstitial nephritis. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), TAHOR (View Tahor Review and Tahor Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

6718935-3 | Acute Respiratory Distress Syndrome, Pulmonary Embolism, Tendon Rupture
on May 04, 2010 Female patient from JAPAN , 48 years of age, was diagnosed with influenza and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: acute respiratory distress syndrome, pulmonary embolism (What is pulmonary embolism?), tendon rupture. Tavanic dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), ORGARAN (View Orgaran Review and Orgaran Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), LODOZ (View Lodoz Review and Lodoz Label ), HYPERIUM (View Hyperium Review and Hyperium Label ). Patient was hospitalized.

6718934-1 | Deafness
on May 04, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with lung disorder and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Tavanic dosage: .

6717610-9 | Cardiovascular Disorder, Dyspnoea, Hypersensitivity
Patient was taking Tavanic (View Usage). Patient had the following side effects: cardiovascular disorder, dyspnoea, hypersensitivity on May 07, 2010 from JAPAN Additional patient health information: Male patient , 44 years of age, was diagnosed with prophylaxis and. Tavanic dosage: . Patient was hospitalized.

6717608-0 | Coma, Disturbance In Attention, Lung Disorder, Myoclonus, Pyrexia
Adverse event was reported on May 07, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with prostatitis and. Location: JAPAN , 78 years of age, After Tavanic was administered, patient had the following side effects: coma, disturbance in attention, lung disorder, myoclonus, pyrexia. During the same period patient was treated with MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), ARICEPT (View Aricept Review and Aricept Label ), CASODEX (View Casodex Review and Casodex Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

6708892-8 | Arthralgia, Back Pain, Faecal Volume Decreased, Heart Rate Increased, Inflammation, Muscular Weakness, Myalgia, Pain In Extremity, Polymyalgia Rheumatica
on Apr 23, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with prostatitis, prostatic specific antigen increased and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), faecal volume decreased, heart rate increased, inflammation, muscular weakness, myalgia, pain in extremity, polymyalgia rheumatica (What is polymyalgia rheumatica?). Tavanic dosage: .

6708887-4 | Cardiovascular Disorder, Dyspnoea, Hypersensitivity
on May 03, 2010 Male patient from JAPAN , 44 years of age, was treated with Tavanic (View Usage). Patient had the following side effects: cardiovascular disorder, dyspnoea, hypersensitivity. Tavanic dosage: . Patient was hospitalized.

6705670-0 | Acute Respiratory Distress Syndrome, Pulmonary Embolism, Tendon Rupture
Patient was taking Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: acute respiratory distress syndrome, pulmonary embolism (What is pulmonary embolism?), tendon rupture on Apr 22, 2010 from JAPAN Additional patient health information: Female patient , 48 years of age, was diagnosed with influenza and. Tavanic dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), ORGARAN (View Orgaran Review and Orgaran Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), LODOZ (View Lodoz Review and Lodoz Label ), HYPERIUM (View Hyperium Review and Hyperium Label ). Patient was hospitalized.

6704660-1 | Purpura, Renal Failure Acute, Septic Shock, Tubulointerstitial Nephritis
Adverse event was reported on Apr 22, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with osteitis and. Location: JAPAN , 79 years of age, Patient experienced the following unwanted or unexpected effects: purpura, renal failure acute, septic shock, tubulointerstitial nephritis. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), TAHOR (View Tahor Review and Tahor Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ). Patient was hospitalized.

6701545-1 | Altered State Of Consciousness, Dehydration, Malaise, Metabolic Acidosis, Pruritus, Rash, Renal Failure Acute, Shock, Vomiting
on Apr 27, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with postoperative wound infection and was treated with Tavanic (View Usage). Patient had the following side effects: altered state of consciousness, dehydration, malaise, metabolic acidosis, pruritus, rash (What is rash?), renal failure acute, shock, vomiting. Tavanic dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), IODOFORM (View Iodoform Review and Iodoform Label ), BETADINE (Irrigation) (View Betadine Review and Betadine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMAREL (View Amarel Review and Amarel Label ), TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

6701544-X | Deafness
on Apr 22, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with lung disorder and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: deafness. Tavanic dosage: .

6697094-X | Ageusia, Anosmia, Hyposmia, Parosmia
Patient was taking Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, anosmia, hyposmia, parosmia on Apr 23, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with tracheobronchitis viral, lung disorder, pyrexia, influenza and. Tavanic dosage: 1 Unit. During the same period patient was treated with TACHIPIRINA (View Tachipirina Review and Tachipirina Label ), PLASIL (View Plasil Review and Plasil Label ).

6697088-4 | Ageusia, Anosmia, Hyposmia, Parosmia
Adverse event was reported on Apr 23, 2010 by a Female patient taking Tavanic (View Usage) (Dosage: 1 Unit) was diagnosed with tracheobronchitis viral, lung disorder, pyrexia, influenza and. Location: JAPAN , 57 years of age, Patient had the following side effects: ageusia, anosmia, hyposmia, parosmia. During the same period patient was treated with TACHIPIRINA (View Tachipirina Review and Tachipirina Label ), PLASIL (View Plasil Review and Plasil Label ).

6691285-X | Hepatic Encephalopathy, Skin Lesion
on Apr 14, 2010 Male patient from JAPAN , 41 years of age, was diagnosed with bacteraemia, sciatica (What is sciatica?), candidiasis and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: hepatic encephalopathy, skin lesion. Tavanic dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6684888-X | Cardiovascular Disorder, Dyspnoea, Hypersensitivity
on Apr 14, 2010 Male patient from JAPAN , 44 years of age, was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, dyspnoea, hypersensitivity. Tavanic dosage: . Patient was hospitalized.

6684779-4 | Loss Of Consciousness, Psychomotor Hyperactivity
Patient was taking Tavanic (View Usage). Patient had the following side effects: loss of consciousness, psychomotor hyperactivity on Apr 09, 2010 from JAPAN Additional patient health information: Male patient , 54 years of age, was diagnosed with prostatitis, benign prostatic hyperplasia and. Tavanic dosage: . During the same period patient was treated with TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), SERENOA REPENS (View Serenoa Repens Review and Serenoa Repens Label ). Patient was hospitalized.

6683237-0 | Hepatic Encephalopathy, Skin Lesion
Adverse event was reported on Apr 08, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with bacteraemia, sciatica (What is sciatica?), candidiasis and. Location: JAPAN , 41 years of age, After Tavanic was administered, patient had the following side effects: hepatic encephalopathy, skin lesion. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6681461-4 | Abdominal Distension, Agitation, Application Site Haematoma, Atelectasis, Implant Site Haemorrhage, Insomnia, Pleural Effusion, Renal Failure Acute
on Apr 03, 2010 Male patient from JAPAN , 76 years of age, was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, agitation, application site haematoma, atelectasis, implant site haemorrhage, insomnia, pleural effusion, renal failure acute. Tavanic dosage: . During the same period patient was treated with SUPREFACT (View Suprefact Review and Suprefact Label ), SECOTEX (View Secotex Review and Secotex Label ), CASODEX (View Casodex Review and Casodex Label ), EPIVAL (View Epival Review and Epival Label ), EBIXIA (View Ebixia Review and Ebixia Label ). Patient was hospitalized.

6680930-0 | Heart Rate Increased, Hypotension, Loss Of Consciousness, Malaise
on Apr 09, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with urinary retention and was treated with Tavanic (View Usage). Patient had the following side effects: heart rate increased, hypotension, loss of consciousness, malaise. Tavanic dosage: . During the same period patient was treated with BENESTAN (View Benestan Review and Benestan Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PLAQUINOL (View Plaquinol Review and Plaquinol Label ), PROTAXIL (View Protaxil Review and Protaxil Label ), NIMED (View Nimed Review and Nimed Label ), TPN (View Tpn Review and Tpn Label ).

6670626-3 | Disorientation, Hallucination
Patient was taking Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: disorientation, hallucination on Mar 29, 2010 from JAPAN Additional patient health information: Female patient , 88 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Tavanic dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6670619-6 | Epicondylitis, Muscle Rupture, Tendon Disorder
Adverse event was reported on Apr 06, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with prostatitis, hypertension, benign prostatic hyperplasia, blood testosterone decreased and. Location: JAPAN , 61 years of age, Patient experienced the following unwanted or unexpected effects: epicondylitis, muscle rupture, tendon disorder. During the same period patient was treated with BLOPRESS PLUS (View Blopress Plus Review and Blopress Plus Label ), ALNA (View Alna Review and Alna Label ), TESTOVIRON DEPOT (View Testoviron-depot Review and Testoviron-depot Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), INFLUENZA VACCINE (View Influenza Vaccine Review and Influenza Vaccine Label ).

6670610-X | Guillain-barre Syndrome
on Mar 29, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with sinusitis (What is sinusitis?), arrhythmia (What is arrhythmia?) and was treated with Tavanic (View Usage). Patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?). Tavanic dosage: . During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6670608-1 | Motor Dysfunction, Musculoskeletal Chest Pain, Myalgia, Sensory Disturbance, Soft Tissue Injury, Tendon Pain
on Mar 29, 2010 Female patient from JAPAN , 41 years of age, was diagnosed with superinfection bacterial, bronchitis (What is bronchitis?), influenza, upper respiratory tract infection, pleurisy, muscle spasms, muscle tightness and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: motor dysfunction, musculoskeletal chest pain, myalgia, sensory disturbance, soft tissue injury, tendon pain. Tavanic dosage: . During the same period patient was treated with PIRACETAM (View Piracetam Review and Piracetam Label ), LIMPTAR (View Limptar Review and Limptar Label ).

6670587-7 | Angioedema, Dyspnoea, Eczema, Oedema Peripheral, Pain In Extremity, Rash Maculo-papular, Tendon Pain
Patient was taking Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, dyspnoea, eczema (What is eczema?), oedema peripheral, pain in extremity, rash maculo-papular, tendon pain on Dec 18, 2009 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with cystitis and. Tavanic dosage: . During the same period patient was treated with FURADANTIN (View Furadantin Review and Furadantin Label ), SAB SIMPLEX (View Sab Simplex Review and Sab Simplex Label ), FORADIL (View Foradil Review and Foradil Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ASTONIN H (View Astonin H Review and Astonin H Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6670583-X | Motor Dysfunction, Musculoskeletal Chest Pain, Myalgia, Sensory Disturbance, Soft Tissue Injury, Tendon Pain
Adverse event was reported on Mar 23, 2010 by a Female patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with superinfection bacterial, bronchitis (What is bronchitis?), influenza, upper respiratory tract infection, pleurisy, muscle spasms, muscle tightness and. Location: JAPAN , 41 years of age, Patient had the following side effects: motor dysfunction, musculoskeletal chest pain, myalgia, sensory disturbance, soft tissue injury, tendon pain. During the same period patient was treated with PIRACETAM (View Piracetam Review and Piracetam Label ), LIMPTAR (View Limptar Review and Limptar Label ).

6670582-8 | Epicondylitis, Muscle Rupture, Tendon Disorder
on Mar 23, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with prostatitis, hypertension, benign prostatic hyperplasia, blood testosterone decreased and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: epicondylitis, muscle rupture, tendon disorder. Tavanic dosage: . During the same period patient was treated with BLOPRESS PLUS (View Blopress Plus Review and Blopress Plus Label ), ALNA (View Alna Review and Alna Label ), TESTOVIRON DEPOT (View Testoviron-depot Review and Testoviron-depot Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), INFLUENZA VACCINE (View Influenza Vaccine Review and Influenza Vaccine Label ).

6668550-5 | Erythema Multiforme, Laryngeal Dyspnoea
on Mar 29, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with lung disorder, oropharyngeal pain, cough, pyrexia and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, laryngeal dyspnoea. Tavanic dosage: . During the same period patient was treated with RULID (View Rulid Review and Rulid Label ). Patient was hospitalized.

6668217-3 | Hepatitis Cholestatic, Papilla Of Vater Stenosis
Patient was taking Tavanic (View Usage). Patient had the following side effects: hepatitis cholestatic, papilla of vater stenosis on Dec 18, 2009 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Tavanic dosage: . During the same period patient was treated with MYRTOL (2*1) (View Myrtol Review and Myrtol Label ). Patient was hospitalized.

6666797-5 | Ligament Rupture, Myalgia
Adverse event was reported on Mar 23, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with cough and. Location: JAPAN , 64 years of age, After Tavanic was administered, patient had the following side effects: ligament rupture, myalgia. During the same period patient was treated with PYOSTACINE (View Pyostacine Review and Pyostacine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

6666796-3 | Cytolytic Hepatitis, Hepatomegaly
on Mar 23, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with bronchopneumopathy, arrhythmia (What is arrhythmia?) and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, hepatomegaly. Tavanic dosage: . During the same period patient was treated with SINTROM (1.5 Units) (View Sintrom Review and Sintrom Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), DIMETANE (View Dimetane Review and Dimetane Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ).

6666795-1 | Contraindication To Medical Treatment, Epilepsy
on Mar 23, 2010 Male patient from JAPAN , 19 years of age, was diagnosed with bronchitis (What is bronchitis?), epilepsy (What is epilepsy?) and was treated with Tavanic (View Usage). Patient had the following side effects: contraindication to medical treatment, epilepsy (What is epilepsy?). Tavanic dosage: . During the same period patient was treated with CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), PNEUMOREL (View Pneumorel Review and Pneumorel Label ), FLUTICASONE PROPIONATE / SALMETEROL (View Fluticasone Propionate / Salmeterol Review and Fluticasone Propionate / Salmeterol Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ).

6666780-X | Convulsion, Flushing, Muscle Spasms, Oedema Peripheral, Pruritus
Patient was taking Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: convulsion, flushing, muscle spasms, oedema peripheral, pruritus on Mar 23, 2010 from JAPAN Additional patient health information: Female patient , 55 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Tavanic dosage: . Patient was hospitalized.

6666779-3 | Rectal Haemorrhage
Adverse event was reported on Mar 23, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with respiratory tract infection and. Location: JAPAN , 82 years of age, Patient experienced the following unwanted or unexpected effects: rectal haemorrhage. Patient was hospitalized.

6666778-1 | Insomnia, Lip Oedema, Nervousness, Skin Exfoliation, Suicidal Ideation
on Mar 23, 2010 Male patient from JAPAN , 41 years of age, was diagnosed with skin infection and was treated with Tavanic (View Usage). Patient had the following side effects: insomnia, lip oedema, nervousness, skin exfoliation, suicidal ideation. Tavanic dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SEVREDOL (View Sevredol Review and Sevredol Label ), ALMAX (View Almax Review and Almax Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ).

6666777-X | Bronchospasm, Rash, Respiratory Failure
on Mar 23, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: bronchospasm, rash (What is rash?), respiratory failure. Tavanic dosage: . Patient was hospitalized.

6666776-8 | Chills, Hallucination, Musculoskeletal Stiffness, Tremor
Patient was taking Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: chills, hallucination, musculoskeletal stiffness, tremor on Mar 23, 2010 from JAPAN Additional patient health information: Female patient , 92 years of age, weighting 180.8 lb, was diagnosed with lung infection, respiratory disorder and. Tavanic dosage: . During the same period patient was treated with SEGURIL (View Seguril Review and Seguril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6662925-6 | Cough, Dehydration, Diarrhoea
Adverse event was reported on Mar 23, 2010 by a Male patient taking Tavanic (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: JAPAN , 87 years of age, Patient had the following side effects: cough, dehydration, diarrhoea. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), ECONAZOLE NITRATE (View Econazole Nitrate Review and Econazole Nitrate Label ). Patient was hospitalized.

6662924-4 | Contraindication To Medical Treatment, Delirium, Hallucination, Visual, Off Label Use, Persecutory Delusion, Psychotic Disorder
on Mar 23, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with lung disorder and was treated with Tavanic (View Usage). After Tavanic was administered, patient had the following side effects: contraindication to medical treatment, delirium, hallucination, visual, off label use, persecutory delusion, psychotic disorder (What is psychotic disorder?). Tavanic dosage: . Patient was hospitalized.

6662923-2 | Haemorrhagic Anaemia, International Normalised Ratio Increased, Muscle Haemorrhage
on Mar 23, 2010 Female patient from JAPAN , 83 years of age, was diagnosed with bronchopneumonia, atrial fibrillation (What is atrial fibrillation?), subendocardial ischaemia and was treated with Tavanic (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic anaemia, international normalised ratio increased, muscle haemorrhage. Tavanic dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ). Patient was hospitalized.

6662922-0 | Guillain-barre Syndrome
Patient was taking Tavanic (View Usage). Patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?) on Mar 23, 2010 from GERMANY Additional patient health information: Female patient , 49 years of age, was diagnosed with sinusitis (What is sinusitis?), arrhythmia (What is arrhythmia?) and. Tavanic dosage: . During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.